Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
J Psychopharmacol ; 34(12): 1457-1460, 2020 12.
Article in English | MEDLINE | ID: mdl-33161817

ABSTRACT

Previous studies suggest that trace conditioning depends on the anterior cingulate cortex (ACC). To examine the role of ACC in trace fear conditioning further, 48 rats were surgically prepared for infusion with saline or 62.5 or 125 µg/side muscimol to inactivate ACC reversibly prior to conditioning. A noise stimulus was followed by a 1 mA footshock, with or without a 10-second trace interval between these events in a conditioned suppression procedure. The trace-conditioned groups (10 seconds) showed less test suppression than the control-conditioned groups (0 seconds). Counter to prediction, there was no effect of muscimol infusion on suppression to the noise stimulus in the 10-second trace groups.


Subject(s)
Association Learning/drug effects , Behavior, Animal/drug effects , Conditioning, Classical/drug effects , Fear/drug effects , GABA Agonists/pharmacology , Gyrus Cinguli/drug effects , Muscimol/pharmacology , Animals , GABA Agonists/administration & dosage , Male , Muscimol/administration & dosage , Rats , Rats, Wistar
2.
Neurobiol Learn Mem ; 164: 107041, 2019 10.
Article in English | MEDLINE | ID: mdl-31351120

ABSTRACT

Appetitive trace conditioning (TC) was examined over 6 months in younger-adult (2-8 months) and middle-aged (12-18 months) male Wistar RccHan rats, to test for early age-related impairment in working memory. Novel object recognition (NOR) was included as a comparison task, to provide a positive control in the event that the expected impairment in TC was not demonstrated. The results showed that TC improved at both ages at the 2 s but not at the 10 s trace interval. There was, however, evidence for reduced improvement from one day to the next in the middle-aged cohort tested with the 2 s trace conditioned stimulus. Moreover, within the 10 s trace, responding progressively distributed later in the trace interval, in the younger-adult but not the middle-aged cohort. Middle-aged rats showed NOR discriminative impairment at a 24 h but not at a 10 min retention interval. Object exploration was overall reduced in middle-aged rats and further reduced longitudinally. At the end of the study, assessing neurochemistry by HPLC-ED showed reduced 5-HIAA/5-HT in the dorsal striatum of the middle-aged rats and some correlations between striatal 5-HIAA/5-HT and activity parameters. Overall the results suggest that, taken in isolation, age-related impairments may be overcome by experience. This recovery in performance was seen despite the drop in activity levels in older animals, which might be expected to contribute to cognitive decline.


Subject(s)
Appetitive Behavior/physiology , Conditioning, Operant/physiology , Corpus Striatum/metabolism , Memory, Short-Term/physiology , Recognition, Psychology/physiology , Animals , Hydroxyindoleacetic Acid/metabolism , Male , Rats, Wistar , Serotonin/metabolism
3.
Brain Behav ; 8(12): e01147, 2018 12.
Article in English | MEDLINE | ID: mdl-30378776

ABSTRACT

INTRODUCTION: Trace conditioning is impaired by lesions to dorsal hippocampus, as well as by treatment with the muscarinic acetylcholine antagonist scopolamine. However, the role of muscarinic receptors within hippocampus has received little attention. METHODS: The present study examined the effects of intra-hippocampal infusion of scopolamine (30 µg/side) in an appetitive (2 vs. 10 s) trace conditioning procedure using sucrose pellets as the unconditioned stimulus (US). Locomotor activity (LMA) was examined in a different apparatus. RESULTS: Intra-hippocampal scopolamine reduced responding to the 2 s trace conditioned stimulus (CS). Intra-hippocampal scopolamine similarly depressed responding within the inter-stimulus interval (ISI) at both 2 and 10 s trace intervals, but there was no such effect in the inter-trial interval. There was also some overall reduction in responding when the US was delivered; significant at the 10 s but not at the 2 s trace interval. A similar pattern of results to that seen in response to the CS during acquisition was shown drug-free (in the 5 s post-CS) in the extinction tests of conditioned responding. LMA was increased under scopolamine. CONCLUSIONS: The results suggest that nonspecific changes in activity or motivation to respond for the US cannot explain the reduction in trace conditioning as measured by reduced CS responding and in the ISI. Rather, the findings of the present study point to the importance of associative aspects of the task in determining its sensitivity to the effects of scopolamine, suggesting that muscarinic receptors in the hippocampus are important modulators of short-term working memory.


Subject(s)
Anticipation, Psychological/drug effects , Conditioning, Classical/drug effects , Hippocampus/drug effects , Muscarinic Antagonists/pharmacology , Scopolamine/pharmacology , Animals , Conditioning, Classical/physiology , Locomotion/drug effects , Male , Memory, Short-Term/drug effects , Rats, Wistar , Receptors, Muscarinic/drug effects , Temporal Lobe/drug effects , Temporal Lobe/physiology
4.
Learn Mem ; 24(7): 310-317, 2017 07.
Article in English | MEDLINE | ID: mdl-28620078

ABSTRACT

Previous in vivo electrophysiological studies suggest that the anterior cingulate cortex (ACgx) is an important substrate of novel object recognition (NOR) memory. However, intervention studies are needed to confirm this conclusion and permanent lesion studies cannot distinguish effects on encoding and retrieval. The interval between encoding and retrieval tests may also be a critical determinant of the role of the ACgx. The current series of experiments used micro-infusion of the GABAA receptor agonist, muscimol, into ACgx to reversibly inactivate the area and distinguish its role in encoding and retrieval. ACgx infusions of muscimol, before encoding did not alter NOR assessed after a delay of 20 min or 24 h. However, when infused into the ACgx before retrieval muscimol impaired NOR assessed after a delay of 24 h, but not after a 20-min retention test. Together these findings suggest that the ACgx plays a time-dependent role in the retrieval, but not the encoding, of NOR memory, neuronal activation being required for the retrieval of remote (24 h old), but not recent (20 min old) visual memory.


Subject(s)
Exploratory Behavior/physiology , Gyrus Cinguli/physiology , Mental Recall/physiology , Recognition, Psychology/physiology , Analysis of Variance , Animals , Discrimination, Psychological/drug effects , Discrimination, Psychological/physiology , Exploratory Behavior/drug effects , GABA-A Receptor Agonists/pharmacology , Gyrus Cinguli/drug effects , Male , Mental Recall/drug effects , Microinjections , Muscimol/pharmacology , Rats , Rats, Wistar , Reaction Time/drug effects , Reaction Time/physiology , Recognition, Psychology/drug effects , Reproducibility of Results , Time Factors
5.
Eur Neuropsychopharmacol ; 25(11): 2145-56, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26277743

ABSTRACT

Previous studies have shown that dopamine D1 receptor antagonists impair novel object recognition memory but the effects of dopamine D1 receptor stimulation remain to be determined. This study investigated the effects of the selective dopamine D1 receptor agonist SKF81297 on acquisition and retrieval in the novel object recognition task in male Wistar rats. SKF81297 (0.4 and 0.8 mg/kg s.c.) given 15 min before the sampling phase impaired novel object recognition evaluated 10 min or 24 h later. The same treatments also reduced novel object recognition memory tested 24 h after the sampling phase and when given 15 min before the choice session. These data indicate that D1 receptor stimulation modulates both the encoding and retrieval of object recognition memory. Microinfusion of SKF81297 (0.025 or 0.05 µg/side) into the prelimbic sub-region of the medial prefrontal cortex (mPFC) in this case 10 min before the sampling phase also impaired novel object recognition memory, suggesting that the mPFC is one important site mediating the effects of D1 receptor stimulation on visual recognition memory.


Subject(s)
Benzazepines/pharmacology , Nootropic Agents/pharmacology , Prefrontal Cortex/metabolism , Receptors, Dopamine D1/agonists , Receptors, Dopamine D1/metabolism , Recognition, Psychology/physiology , Animals , Dose-Response Relationship, Drug , Male , Microinjections , Motor Activity/drug effects , Neuropsychological Tests , Prefrontal Cortex/drug effects , Rats, Wistar , Recognition, Psychology/drug effects , Time Factors
6.
Psychopharmacology (Berl) ; 232(14): 2619-29, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25743759

ABSTRACT

RATIONALE: Dopamine D1-like receptor signalling is involved in contextual fear conditioning, but the brain regions involved and its role in other contextual fear memory processes remain unclear. OBJECTIVES: The objective of this study was to investigate (1) the effects of SCH 23390, a dopamine D1/D5 receptor antagonist, on contextual fear memory encoding, retrieval and reconsolidation, and (2) if the effects of SCH 23390 on conditioning involve the dorsal hippocampus (DH) and/or basolateral amygdala (BLA). METHODS: Rats were used to examine the effects of systemically administering SCH 23390 on the acquisition, consolidation, retrieval and reconsolidation of contextual fear memory, and on locomotor activity and shock sensitivity. We also determined the effects of MK-801, an NMDA receptor antagonist, on contextual fear memory reconsolidation. The effects of infusing SCH 23390 locally into DH or BLA on contextual fear conditioning and locomotor activity were also examined. RESULTS: Systemic administration of SCH 23390 impaired contextual fear conditioning but had no effects on fear memory consolidation, retrieval or reconsolidation. MK-801 was found to impair reconsolidation, suggesting that the behavioural parameters used allowed for the pharmacological disruption of memory reconsolidation. The effects of SCH 23390 on conditioning were unlikely the result of any lasting drug effects on locomotor activity at memory test or any acute drug effects on shock sensitivity during conditioning. SCH 23390 infused into either DH or BLA impaired contextual fear conditioning and decreased locomotor activity. CONCLUSIONS: These findings suggest that dopamine D1-like receptor signalling in DH and BLA contributes to the acquisition of contextual fear memory.


Subject(s)
Amygdala/drug effects , Conditioning, Operant/drug effects , Fear/drug effects , Hippocampus/drug effects , Receptors, Dopamine D1/antagonists & inhibitors , Signal Transduction/drug effects , Animals , Benzazepines/pharmacology , Dizocilpine Maleate/pharmacology , Dopamine Antagonists/pharmacology , Electroshock , Male , Memory/drug effects , Motor Activity/drug effects , Rats
7.
Front Syst Neurosci ; 8: 160, 2014.
Article in English | MEDLINE | ID: mdl-25249948

ABSTRACT

Distinctions along the dorsal-ventral axis of medial prefrontal cortex (mPFC), between anterior cingulate (AC), prelimbic (PL), and infralimbic (IL) sub-regions, have been proposed on a variety of neuroanatomical and neurophysiological grounds. Conventional lesion approaches (as well as some electrophysiological studies) have shown that these distinctions relate to function in that a number behavioral dissociations have been demonstrated, particularly using rodent models of attention, learning, and memory. For example, there is evidence to suggest that AC has a relatively greater role in attention, whereas IL is more involved in executive function. However, the well-established methods of behavioral neuroscience have the limitation that neuromodulation is not addressed. The neurotoxin 6-hydroxydopamine has been used to deplete dopamine (DA) in mPFC sub-regions, but these lesions are not selective anatomically and noradrenalin is typically also depleted. Microinfusion of drugs through indwelling cannulae provides an alternative approach, to address the role of neuromodulation and moreover that of specific receptor subtypes within mPFC sub-regions, but the effects of such treatments cannot be assumed to be anatomically restricted either. New methodological approaches to the functional delineation of the role of mPFC in attention, learning and memory will also be considered. Taken in isolation, the conventional lesion methods which have been a first line of approach may suggest that a particular mPFC sub-region is not necessary for a particular aspect of function. However, this does not exclude a neuromodulatory role and more neuropsychopharmacological approaches are needed to explain some of the apparent inconsistencies in the results.

8.
Psychopharmacology (Berl) ; 202(1-3): 307-13, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18985321

ABSTRACT

RATIONALE: Anti-psychotic drugs are widely recognised to produce beneficial effects on impaired cognition in schizophrenia but their mechanism of action is poorly understood. The prefrontal cortex (PFC) and nucleus accumbens (NAC) are key brain loci considered to mediate many of the cognitive deficits associated with schizophrenia and related disorders. OBJECTIVES: To investigate (1) the effects of selective damage to the PFC on visuo-spatial attention and cognition in the rat and (2) the ability of the anti-psychotic drug sulpiride after its intra-NAC administration to ameliorate cognitive and behavioural deficits produced by lesions of the PFC. METHODS: Selective lesions of the medial PFC were made using quinolinic acid in rats previously trained on a five-choice serial reaction time task of sustained visual attention (n = 7). Sham rats received phosphate-buffered saline infusions (n = 7). Following a period of recovery, low doses of sulpiride (0.5 ng or 1 ng) were infused into the core sub-region of the NAC of sham and lesioned rats immediately prior to testing on the five-choice task. RESULTS: Lesions of the medial PFC produced a range of impairments on the five-choice task, including decreased attentional accuracy, slower latencies to respond correctly and increased omissions and premature responses, the latter an operational measure of impulsivity. Intra-NAC sulpiride dose-dependently ameliorated the increased impulsivity and attentional impairment present in PFC-lesioned rats. CONCLUSIONS: These findings suggest that attentional and cognitive impairment in schizophrenia may be determined in part by a dysregulation of the subcortical dopamine systems occurring as a consequence of damage to the PFC.


Subject(s)
Antipsychotic Agents/pharmacology , Attention/drug effects , Dopamine Antagonists/pharmacology , Mental Disorders/chemically induced , Mental Disorders/psychology , Nucleus Accumbens/physiology , Prefrontal Cortex/physiology , Receptors, Dopamine D2/drug effects , Receptors, Dopamine D3/drug effects , Sulpiride/pharmacology , Animals , Antipsychotic Agents/administration & dosage , Dopamine Antagonists/administration & dosage , Dose-Response Relationship, Drug , Impulsive Behavior/chemically induced , Impulsive Behavior/psychology , Male , Microinjections , Nucleus Accumbens/pathology , Prefrontal Cortex/pathology , Psychomotor Performance/drug effects , Rats , Reaction Time/drug effects , Sulpiride/administration & dosage
9.
Neuropsychopharmacology ; 33(10): 2398-406, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18046307

ABSTRACT

Serotonin (5-HT) is thought to play an important role in the regulation of behavioral inhibition. Studies manipulating 5-HT function in the rodent brain indicate that 5-HT receptors regulate distinct forms of impulsive behavior, including impulsive responding in the 5-choice serial reaction time task (5CSRTT). The present study investigates the loci of effects mediated by 5-HT(2A) and 5-HT(2C) receptors in attention and inhibitory response control using microinfusions targeted at the nucleus accumbens (NAc), prelimbic cortex (PL) and infralimbic cortex (IL). Rats were implanted with bilateral guide cannulas and received infusions of the selective 5-HT(2A) receptor antagonist M100907 (0.1 and 0.3 microg) or selective 5-HT(2C) receptor antagonist SB242084 (0.1 and 0.5 microg) immediately prior to testing. The results show that intra-NAc infusions of M100907 significantly decrease impulsive responding on the 5CSRTT and at the highest dose increased omissions as well. By contrast, infusions of SB242084 into the NAc selectively and dose-dependently increased impulsivity. Neither M100907 nor SB242084 significantly altered impulsive responding following either intra-PL or intra-IL administration. However, SB242084 significantly decreased omissions following intra-PL administration (0.5 microg only). These data reveal opposing effects on impulsivity following 5-HT(2A) and 5-HT(2C) blockade in the NAc. Our results suggest that the NAc, but not the PL or IL, is implicated in the mediation of the effects of M100907 and SB242084 on inhibitory response control during baseline 5CSRTT performance.


Subject(s)
Choice Behavior/physiology , Neural Inhibition/physiology , Nucleus Accumbens/metabolism , Reaction Time/physiology , Receptor, Serotonin, 5-HT2A/metabolism , Receptor, Serotonin, 5-HT2C/metabolism , Aminopyridines/pharmacology , Animals , Attention/drug effects , Attention/physiology , Brain Chemistry/drug effects , Brain Chemistry/physiology , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Choice Behavior/drug effects , Dose-Response Relationship, Drug , Fluorobenzenes/pharmacology , Impulsive Behavior/metabolism , Impulsive Behavior/physiopathology , Indoles/pharmacology , Limbic System/drug effects , Limbic System/metabolism , Male , Neural Inhibition/drug effects , Neuropsychological Tests , Nucleus Accumbens/drug effects , Piperidines/pharmacology , Rats , Reaction Time/drug effects , Receptor, Serotonin, 5-HT2A/drug effects , Receptor, Serotonin, 5-HT2C/drug effects , Serotonin/metabolism , Serotonin Antagonists/pharmacology , Synaptic Transmission/drug effects , Synaptic Transmission/physiology
10.
Prog Neurobiol ; 74(5): 301-20, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15582224

ABSTRACT

One of the most common paradigms used to study the biological basis of emotion, as well as of learning and memory, is Pavlovian fear conditioning. In the acquisition phase of a fear conditioning experiment, an emotionally neutral conditioned stimulus (CS)--which can either be a discrete stimulus, such as a tone, or a contextual stimulus, such as a specific environment--is paired with an aversive unconditioned stimulus (US), for example a foot shock. As a result, the CS elicits conditioned fear responses when subsequently presented alone during the expression phase of the experiment. While considerable work has been done in relating specific circuits of the brain to fear conditioning, less is known about its regulation by neuromodulators; the understanding of which would be of therapeutic relevance for fear related diseases such as phobia, panic attacks, post traumatic stress disorder, obsessive compulsive disorder, or generalized anxiety disorder. Dopamine is one of the neuromodulators most potently acting on the mechanisms underlying states of fear and anxiety. Recently, a growing body of evidence has suggested that dopaminergic mechanisms are significant for different aspects of affective memory, namely its formation, expression, retrieval, and extinction. The aim of this review is to clarify the complex actions of dopamine in fear conditioning with respect to the wide-spread distribution of dopaminergic innervation over structures constituting the fear related circuitry. A particular effort is made to understand how dopamine in the amygdala, medial prefrontal cortex and nucleus accumbens--target structures of the mesolimbic dopamine system originating from the ventral tegmental area--could relate to different aspects of fear conditioning.


Subject(s)
Conditioning, Psychological/physiology , Dopamine/metabolism , Fear/physiology , Limbic System/physiology , Animals , Humans , Limbic System/cytology , Memory/physiology , Neural Pathways/physiology , Neurons/physiology , Prefrontal Cortex/physiology
11.
Cereb Cortex ; 13(4): 371-80, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12631566

ABSTRACT

Previous studies have demonstrated activation of dopamine transmission in the medial prefrontal cortex (mPFC) by conditioned fear stimuli. Therefore, the present study investigated the functional significance of mPFC dopamine for a conditioned fear response to a tone. We examined the effects of inhibition or stimulation of mPFC dopamine transmission by local microinfusion of the D1/D2-receptor antagonist cis-flupenthixol or the indirect dopamine receptor agonist D-amphetamine, respectively, in a classical fear-conditioning paradigm in Wistar rats. Rats received tone-shock pairings and were later exposed to the tone alone. Freezing was used as measure of conditioned fear. Presence of the drugs in the mPFC during the tone-shock pairings did not affect freezing during subsequent presentation of the tone alone. However, when cis-flupenthixol and D-amphetamine were present in the mPFC during presentation of the tone alone, freezing to the tone was reduced. We demonstrated that the decreased freezing could be explained neither by state dependency nor infusion-induced alterations in activity. Our data indicate that mPFC dopamine transmission is important for the retrieval/expression, but not the formation, of conditioned fear. The reduction of conditioned fear by prefrontal infusion of both cis-flupenthixol and D-amphetamine may reflect normal expression of conditioned fear requires an optimal level of mPFC dopamine activity.


Subject(s)
Conditioning, Psychological/physiology , Fear/physiology , Prefrontal Cortex/physiology , Receptors, Dopamine/physiology , Synaptic Transmission/physiology , Animals , Dopamine Agonists/pharmacology , Dopamine Antagonists/pharmacology , Immobilization/physiology , Male , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...